뉴스 동향
  • Disposable Intranasal Atomization Device—an ideal partner for Nasal Spray Vaccine
    2023-01-17
    Recently, the nasal spray COVID-19 vaccine, VectorFlu ONE, was approved for emergency use by the national authorities in the Chinese mainland. The vaccine has been jointly developed by Hong Kong University, Xiamen University and Wantai Biopharmaceutical Company. The nasal spray vaccine functions by NEST Pre-filled Disposable Intranasal Atomization Device.
  • NEST Tube is adopted by WHO, Uganda to test Ebola Vaccines in outbreak
    2022-11-24
    NEST Product is adopted by WHO, Uganda in the clinic trial on three candidate Ebola Vaccines, which is launched by the World Health Organization collaborating with the government of Uganda. As is revealed by WHO, the first doses of the three candidates vaccines against the Ebola Virus Sudan are expected to arrive in Uganda in the following week.
  • Cryogenic Vials Renewal
    2022-11-23
    About Cell Cryopreservation Cell cryopreservation is a long-term cell storage technique that places cells in a low-temperature environment to slow down its metabolism. Placing and storing cells in liquid nitrogenof gas phase at -196°C can temporarily suspend cells’ growth, and preserve their certain cellular properties in preparation of later thawing when needed. For cryopreservation, NEST offers three kinds of Cryogenic Vials: 1. Regular Cryogenic Vials (No codes) 2. 2D Matrix Cryogenic Vial (Barcode) 3. Three-code-in-one SBS Cryogenic Vial. (Numeric code, Barcode, QR code)